Clinical Trial

An Imaging Study of Polyvascular Disease

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 27, 2024 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
1. Establish a multimodality imaging database for PVD, improve the one-stop screening process for early PVD based on artificial intelligence, build a full-cycle control information platform, and promote the construction and standardization of a multidisciplinary co-morbidity and co-management diagnosis and treatment model. 2. Based on non-invasive, zero-contrast ocular OCTA combined with one-stop CTA imaging of the heart and brain, construct an integrated "eye-heart-brain" early warning model for PVD, and explore a potential non-invasive and convenient early warning system for PVD. 3. Based on the multi-omics, investigate EVs-mediated intercellular communication network, elucidate the roles and regulatory mechanisms of EVs in the development of PVD, search for potential targets for intervention, and construct an artificial intelligence-based "pan-vascular score" risk assessment system based on the combination of multi-modality imaging and multi-omics biomarkers.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-08-28; most recent amendment 2024-12-22.
Status change: Not Yet Recruiting → Recruiting 2023-10-19
Trial Details
NCT Number NCT06016608
Lead Sponsor Harbin Medical University
Conditions Polyvascular Disease
Enrollment 1,100 participants
Start Date 2023-10-18
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-12-27